Afrezza® INHALE-1 Study in Pediatrics
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kevin Kaiserman
Mannkind Corporation
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
39 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- Children'S Hospital of Orange County
Orange, California, United States
- Stanford University
Palo Alto, California, United States
- Sutter Institute for Medical Research (formerly Center of Excellence in Diabetes and Endocrinology)
Sacramento, California, United States
- University of California San Diego, Rady Children'S Hospital
San Diego, California, United States
- University of California San Francisco
San Francisco, California, United States
- Yale New Haven Hospital
New Haven, Connecticut, United States
- Nemours Children'S Hospital, Delaware
Wilmington, Delaware, United States
- University of Florida
Gainesville, Florida, United States
- Joe Dimaggio Children'S Hospital
Hollywood, Florida, United States
- Advent Health Orlando
Orlando, Florida, United States
- University of South Florida
Tampa, Florida, United States
- Emory University, Children'S Healthcare of Atlanta
Atlanta, Georgia, United States
- Rocky Mountain Clinical Research
Idaho Falls, Idaho, United States
- Indiana University
Indianapolis, Indiana, United States
- University of Iowa
Iowa City, Iowa, United States
- Iowa Diabetes Research, Idr
West Des Moines, Iowa, United States
- University of Louisville, Norton Children'S Hospital
Louisville, Kentucky, United States
- Dr. Barry J. Reiner
Baltimore, Maryland, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- Joslin Diabetes Center
Boston, Massachusetts, United States
- Michigan Pediatric Endocrine and Diabetes Services
Livonia, Michigan, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- Children'S Mercy Hospital
Kansas City, Missouri, United States
- the Docs
Las Vegas, Nevada, United States
- Atlantic Health
Morristown, New Jersey, United States
- Ubmd Pediatrics Buffalo
Buffalo, New York, United States
- Nyu Langone, Hassenfeld Children'S Hospital
New York, New York, United States
- Cincinnati Children'S Hospital
Cincinnati, Ohio, United States
- University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States
- Oklahoma Children'S Hospital
Oklahoma City, Oklahoma, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- Am Diabetes and Endocrinology Center
Bartlett, Tennessee, United States
- Ut Southwestern
Dallas, Texas, United States
- Dhr Health
Edinburg, Texas, United States
- Diabetes & Glandular Disease Clinic, Dgd
San Antonio, Texas, United States
- Virginia Commonwealth University
Richmond, Virginia, United States
- Seattle Children'S
Seattle, Washington, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Sept 2021
- Primary completion
- 3 Oct 2024
- Completion
- 29 Apr 2025
- Last update posted
- 6 May 2025
- Registered enrollment
- 319
- Registry id
- NCT04974528
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.